These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 30940422

  • 1. Clinical impact of splenic hilar dissection with splenectomy for gastric stump cancer.
    Watanabe M, Kinoshita T, Morita S, Yura M, Tokunaga M, Otsuki S, Yamagata Y, Kaito A, Yoshikawa T, Katai H.
    Eur J Surg Oncol; 2019 Aug; 45(8):1505-1510. PubMed ID: 30940422
    [Abstract] [Full Text] [Related]

  • 2. The Therapeutic Survival Benefit of Splenic Hilar Nodal Dissection for Advanced Proximal Gastric Cancer Invading the Greater Curvature.
    Yura M, Yoshikawa T, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T.
    Ann Surg Oncol; 2019 Mar; 26(3):829-835. PubMed ID: 30569298
    [Abstract] [Full Text] [Related]

  • 3. Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan.
    Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T.
    World J Surg; 2016 May; 40(5):1165-71. PubMed ID: 26630939
    [Abstract] [Full Text] [Related]

  • 4. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients.
    Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, Otsuji E.
    Gastric Cancer; 2011 Jun; 14(2):172-7. PubMed ID: 21331530
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types.
    Kano Y, Ohashi M, Ida S, Kumagai K, Makuuchi R, Sano T, Hiki N, Nunobe S.
    Gastric Cancer; 2020 Sep; 23(5):927-936. PubMed ID: 32307689
    [Abstract] [Full Text] [Related]

  • 6. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
    Liu K, Chen XZ, Zhang YC, Zhang WH, Chen XL, Sun LF, Yang K, Zhang B, Zhou ZG, Hu JK.
    Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
    [Abstract] [Full Text] [Related]

  • 7. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL, Sun Z, Wang ZN, Xu YY, Huang BJ, Xu Y, Zhu Z, Xu HM.
    J Surg Oncol; 2012 Jun 15; 105(8):786-92. PubMed ID: 22105768
    [Abstract] [Full Text] [Related]

  • 8. Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
    Ding P, Gao Z, Zheng C, Chen J, Li K, Gao S.
    BMC Cancer; 2019 Sep 11; 19(1):905. PubMed ID: 31510966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Subtotal gastrectomy with limited lymph node dissection is a feasible treatment option for patients with early gastric stump cancer.
    Irino T, Hiki N, Nunobe S, Ohashi M, Tanimura S, Sano T, Yamaguchi T.
    J Gastrointest Surg; 2014 Aug 11; 18(8):1429-33. PubMed ID: 24944156
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.
    Sasada S, Ninomiya M, Nishizaki M, Harano M, Ojima Y, Matsukawa H, Aoki H, Shiozaki S, Ohno S, Takakura N.
    Anticancer Res; 2009 Aug 11; 29(8):3347-51. PubMed ID: 19661354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgical treatment of non-early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer.
    Ohashi M, Morita S, Fukagawa T, Kushima R, Katai H.
    J Surg Oncol; 2015 Feb 11; 111(2):208-12. PubMed ID: 25175816
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma.
    Jeong O, Jung MR, Ryu SY.
    Eur J Surg Oncol; 2019 Mar 11; 45(3):432-438. PubMed ID: 30389304
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
    Ji X, Fu T, Bu ZD, Zhang J, Wu XJ, Zong XL, Jia ZY, Fan B, Zhang YN, Ji JF.
    BMC Cancer; 2016 Oct 03; 16(1):765. PubMed ID: 27716191
    [Abstract] [Full Text] [Related]

  • 19. Spleen-preserving lymphadenectomy versus splenectomy in laparoscopic total gastrectomy for advanced gastric cancer.
    Son SY, Shin DJ, Park YS, Oo AM, Jung DH, Lee CM, Ahn SH, Park DJ, Kim HH.
    Surg Oncol; 2017 Jun 03; 26(2):207-211. PubMed ID: 28577727
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.